Cargando…

The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

BACKGROUND: Limited data exist on the real‐world costs of applying whole‐genome analysis (WGA) in a clinical setting. We estimated the costs of applying WGA to guide treatments for patients with advanced cancers and characterized how costs evolve over time. METHODS: The setting is the British Columb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weymann, Deirdre, Laskin, Janessa, Roscoe, Robyn, Schrader, Kasmintan A., Chia, Stephen, Yip, Stephen, Cheung, Winson Y., Gelmon, Karen A., Karsan, Aly, Renouf, Daniel J., Marra, Marco, Regier, Dean A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418/ https://www.ncbi.nlm.nih.gov/pubmed/28546995 http://dx.doi.org/10.1002/mgg3.281

Ejemplares similares

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
por: Weymann, Deirdre, et al.
Publicado: (2021)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2021)

Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology
por: Dixon, Katherine, et al.
Publicado: (2020)

Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
por: Pollard, Samantha, et al.
Publicado: (2020)

Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach
por: Pollard, Samantha, et al.
Publicado: (2023)

CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
por: Cremin, Carol, et al.
Publicado: (2018)

Corrigendum: Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2018)

Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2017)

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
por: Laskin, Janessa, et al.
Publicado: (2015)

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60
por: Regier, Dean A., et al.
Publicado: (2022)

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing
por: Thibodeau, My Linh, et al.
Publicado: (2020)

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy
por: Geller, Georgia, et al.
Publicado: (2017)

Genetic matching for time-dependent treatments: a longitudinal extension and simulation study
por: Weymann, Deirdre, et al.
Publicado: (2023)

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
por: Wong, Hui-li, et al.
Publicado: (2018)

Germline Testing and Somatic Tumor Testing for BRCA1/2 Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?
por: Kwon, Janice S., et al.
Publicado: (2022)

Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers
por: Grewal, Jasleen K., et al.
Publicado: (2019)

Detection and genomic characterization of a mammary-like adenocarcinoma
por: Grewal, Jasleen K., et al.
Publicado: (2017)

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes
por: Pender, Alexandra, et al.
Publicado: (2020)

Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System
por: Richardson, Matthew, et al.
Publicado: (2020)

Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2018)

Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant
por: Majounie, Elisa, et al.
Publicado: (2020)

Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis
por: Thibodeau, My Linh, et al.
Publicado: (2019)

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment
por: Weymann, Deirdre, et al.
Publicado: (2018)

Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma
por: Ko, Jenny J., et al.
Publicado: (2018)

Molecular characterization of ERBB2-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive cases
por: Owen, Daniel R., et al.
Publicado: (2018)

Impact of oncologist payment method on health care outcomes, costs, quality: a rapid review
por: McPherson, Emily, et al.
Publicado: (2016)

“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management
por: Shickh, Salma, et al.
Publicado: (2022)

Modeling manual wheelchair propulsion cost during straight and curvilinear trajectories
por: Misch, Jacob, et al.
Publicado: (2020)

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
por: Cressman, Sonya, et al.
Publicado: (2016)

Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
por: Tsang, Erica S., et al.
Publicado: (2023)

High‐Cost Users of Prescription Drugs: A Population‐Based Analysis from British Columbia, Canada
por: Weymann, Deirdre, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care
por: Raymakers, Adam J. N., et al.
Publicado: (2021)

Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer
por: Li, Kelly, et al.
Publicado: (2023)

TMBur: a distributable tumor mutation burden approach for whole genome sequencing
por: Titmuss, Emma, et al.
Publicado: (2022)

The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system
por: Wong, Derek, et al.
Publicado: (2019)

Cost-Effectiveness of Surveillance after Metastasectomy of Stage IV Colorectal Cancer
por: Ding, Philip Q., et al.
Publicado: (2023)

Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing
por: Parker, Jeremy D.K., et al.
Publicado: (2016)

Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making
por: Chahal, Manik, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_av2gnakfp11oln5l43i4ae8gf4